Removal of ivermectin from aqueous media using commercial, bentonite-based organophilic clay as an adsorbent

The worldwide use of pharmaceuticals is of concern to those researchers who develop new techniques for the removal of these compounds from the aquatic medium. The objective of the present work was to characterize and evaluate the performance of a commercial, bentonite-based organophilic clay in removing ivermectin from aqueous solution. The adsorbent was characterized by nitrogen physisorption, thermogravimetric-differential scanning calorimetry (TG-DSC), X-ray diffraction (XRD) and Fourier-transform infrared spectroscopy (FTIR). Batch-scale adsorption experiments were performed to evaluate the kinetics, isotherms, thermodynamics and effect of pH on removal of this drug and reuse of the clay. The bentonite has a small specific surface area with an irregular surface. The Elovich kinetic model fits the experimental data better than other models, indicating that chemisorption contributes to drug removal in this case. The Langmuir and Sips isothermal models best fit the experimental equilibrium data. The process was shown to be favorable (ΔG°ads<0), endothermic (ΔH°ads>0), with an increase in the degrees of freedom at the solid–liquid interface (ΔS°ads>0), and with characteristics of a physical-chemical adsorption process (Ea = 11.065 kJ mol–1) under the study conditions. Adsorption was favored at the natural pH of the solution and the organophilic clay could be regenerated with water and reused in consecutive adsorption cycles. The amount of ivermectin adsorbed on the organophilic clay ranged from 1.78 to 3.88 mg g–1. The organophilic clay was shown to be a cost-effective potential adsorbent for ivermectin-contaminated water-treatment applications.

Photocatalytic degradation of hydroxychloroquine using ZnO supported on clinoptilolite zeolite.

The objective of this work was to evaluate the photocatalytic activity of zinc oxide catalysts supported on natural zeolite clinoptilolite for photocatalytic degradation of the drug hydroxychloroquine, used in the treatment of malaria and which has been tested in the treatment of COVID-19. To synthesize 10%ZnOCP and 15%ZnOCP catalysts, the wet impregnation methodology was used. The raw and synthesized catalysts were characterized by XRD, SEM, XRF, BET, DRS, PCZ, FT-IR and PL. The degradation of hydroxychloroquine was calculated using UV-vis absorption from the samples before and after the photocatalytic process. The maximum percentage of degradation (96%) was obtained with the operational parameters of C0 = 10 mg L-1; Ccat = 2 g L-1 of 15%ZnOCP; pH = 7.5; UV-A radiation. Ecotoxicological tests against the bioindicators Lactuca sativa and Artemia salina confirmed the reduction of effluent toxicity after treatment.

A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.

On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. The outbreak caused a worldwide impact, becoming a health threat to the general population and its professionals. To date, there are no specific antiviral treatments or vaccines for the COVID-19 infection, however, some drugs are being clinically tested. The use of these drugs on large scale raises great concern about their imminent environmental risk, since the elimination of these compounds by feces and urine associated with the inefficiency of sewage treatment plants in their removal can result in their persistence in the environment, putting in risk the health of humans and of other species. Thus, the goal of this work was to conduct a review of other studies that evaluated the presence of the drugs chloroquine, hydroxychloroquine, azithromycin, ivermectin, dexamethasone, remdesivir, favipiravir and some HIV antivirals in the environment. The research indicated the presence of these drugs in the environment in different regions, with concentration data that could serve as a basis for further comparative studies following the pandemic.